Security key
50127T109
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)
CUSIP: 50127T109
Q3 2017 13F Holders as of 30 Sep 2017
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 19,416,540
- Total 13F value
- $290,234,810
- Share change
- +8,604,797
- SEC-reported price per share
- $14.95
- Number of holders
- 64
- Value change
- +$128,771,717
- Number of buys
- 50
- Number of sells
- 12
- Shares outstanding
- 88,321,513
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2017
Institutions
64
Top holders
10
KURA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2017
Previous quarter: Q2 2017
Kura Oncology, Inc. SEC filings
Kura Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 50127T109
Recent filing periods:
Ownership snapshot
Top reported holders of KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2017
13F
Lead comparable stake: 3.2%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 3.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
3.2%
PFM Health Sciences, LP
2.3%
EcoR1 Capital, LLC
2.3%
BlackRock Finance, Inc.
0.67%
MORGAN STANLEY
0.65%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
3.2%
|
$26,188,000
2,815,919 shares
|
— | 30 Jun 2017 |
| PFM Health Sciences, LP |
13F
Company
|
2.3%
|
$18,949,000
2,037,493 shares
|
— | 30 Jun 2017 |
| EcoR1 Capital, LLC |
13F
Company
|
2.3%
|
$18,913,000
2,033,622 shares
|
— | 30 Jun 2017 |
| BlackRock Finance, Inc. |
13F
Company
|
0.67%
|
$5,532,000
594,895 shares
|
— | 30 Jun 2017 |
| MORGAN STANLEY |
13F
Company
|
0.65%
|
$5,321,000
572,223 shares
|
— | 30 Jun 2017 |
| Boxer Capital, LLC |
13F
Company
|
0.6%
|
$4,959,000
533,251 shares
|
— | 30 Jun 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
64
Shares
19,416,540
Rows available
64
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
42
Q3 2017 holders
64
Holder diff
22
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 value | Q3 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend